Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    MANNOSE-BINDING PROTEIN DEFICIENCY
Show Display Options
Rank Status Study
1 Withdrawn Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia
Conditions: Fever, Sweats, and Hot Flashes;   Infection;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Neutropenia;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Biological: recombinant human mannose-binding lectin
2 Completed Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia
Conditions: MBL-Deficient;   Neutropenia
Interventions: Drug: Mannan Binding Lectin (MBL);   Drug: Mannan Binding Lectin
3 Completed Association Between Deficiency of MBL (Mannose-Binding Lectin) and Polymorphisms in MBL2 Gene to Urinary Tract Infection
Condition: Recurrent Urinary Tract Infections
Intervention:
4 Withdrawn A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia
Conditions: Cancer;   Hematologic Diseases;   Fever;   Neutropenia
Intervention: Drug: Intravenous recombinant human mannose binding lectin

Indicates status has not been verified in more than two years